Research map: High Prevalence of Preexisting Neutralizing Antibodies Against Adeno-Associated Virus Capsids in Mongolian People with Hemophilia

Back to the article

Papers in this map

  1. Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues · Guangping Gao · 2004 · 1088 citations · Cited by this paper
  2. Retroviral Transduction of Human CD4 + T Cells with Membrane-Attached IL-10 Generates Type 1-Like Regulatory T Cells · 2026 · Related
  3. AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer · Helena Costa Verdera · 2020 · 655 citations · Cited by this paper
  4. Optimization of Alpha-1 Antitrypsin Expression from Adeno-Associated Virus Vectors · 2026 · Related
  5. Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B · Steven W. Pipe · 2023 · 367 citations · Cited by this paper
  6. Prenatal Intraportal Delivery of Polymeric Nanoparticles to Fetal Rhesus Monkeys ( Macaca mulatta ) · 2026 · Related
  7. Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease · Kiran Musunuru · 2025 · 357 citations · Cited by this paper
  8. Quantification of Lentiviral Vectors with Nucleic Acid Dyes · 2026 · Related
  9. Haemophilia · Erik E. Berntorp · 2021 · 332 citations · Cited by this paper
  10. CAR-T Cell Therapy: Manufacturing Platforms and Clinical Consequences · 2026 · Related
  11. Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A · Johnny Ndoni Mahlangu · 2023 · 204 citations · Cited by this paper
  12. A Review of the Challenge of Pre-Existing Humoral Immunity in Adeno-Associated Virus Gene Therapy and Potential Solutions · 2026 · Related
  13. Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper · Tong‐Yuan Yang · 2022 · 127 citations · Cited by this paper
  14. Capsid Engineering of Adeno-Associated Viruses for Targeted Gene Therapy in Kidney Diseases · 2026 · Related
  15. Exposure to wild-type AAV drives distinct capsid immunity profiles in humans · Klaudia Kuranda · 2018 · 108 citations · Cited by this paper
  16. Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing · 2026 · Related
  17. Understanding AAV vector immunogenicity: from particle to patient · Bijay P. Dhungel · 2024 · 83 citations · Cited by this paper
  18. Helper-Dependent Adenoviral Vectors: Recent Advances and Emerging Applications · 2026 · Related
  19. Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapies · Amit Chhabra · 2024 · 73 citations · Cited by this paper
  20. Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A · Alok Srivastava · 2024 · 58 citations · Cited by this paper
  21. Gene therapy for hemophilia – From basic science to first approvals of “one-and-done” therapies · Roland W. Herzog · 2025 · 35 citations · Cited by this paper
  22. Preexisting antibody assays for gene therapy: Considerations on patient selection cutoffs and companion diagnostic requirements · Manuela Braun · 2024 · 31 citations · Cited by this paper
  23. A sensitive and reproducible cell-based assay via secNanoLuc to detect neutralizing antibody against adeno-associated virus vector capsid · Nemekhbayar Baatartsogt · 2021 · 27 citations · Cited by this paper
  24. The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs · Yuji Kashiwakura · 2022 · 27 citations · Cited by this paper
  25. Multicenter assessment and longitudinal study of the prevalence of antibodies and related adaptive immune responses to AAV in adult males with hemophilia · Ingrid Pabinger · 2024 · 26 citations · Cited by this paper
  26. Hepatitis B, C, and D Virus Infection among Population Aged 10–64 Years in Mongolia: Baseline Survey Data of a Nationwide Cancer Cohort Study · Davaalkham Dambadarjaa · 2022 · 21 citations · Cited by this paper
  27. Hepatitis E Virus (HEV) Spreads from Pigs and Sheep in Mongolia · Enkhbaatar Batmagnai · 2023 · 15 citations · Cited by this paper
  28. Helicobacter pylori Across Continents: Contrasts in Epidemiology, Genetics, Clinical Impact, and Management Between East and West · Ken Namikawa · 2025 · 14 citations · Cited by this paper
  29. The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025 · Glenn F. Pierce · 2025 · 13 citations · Cited by this paper
  30. Contemporary approaches to treat people with hemophilia: what’s new and what’s not? · Leonard A. Valentino · 2025 · 10 citations · Cited by this paper
  31. Global prophylaxis trends in hemophilia: a macroeconomic analysis and its association with world development indicators · M. Joseph John · 2024 · 8 citations · Cited by this paper
  32. Prevalence of Neutralizing Antibodies Against AAV Serotypes 2 and 9 in Healthy Participants from Multiple Centers Across China and Patients with DMD/BMD · Xuzhen Qin · 2024 · 8 citations · Cited by this paper
  33. The strength and weakness of Mongolian healthcare: from nomadic Gobi to Ulaanbaatar · Wei‐Ti Chen · 2025 · 7 citations · Cited by this paper
  34. Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial · Robert Klamroth · 2026 · 6 citations · Cited by this paper
  35. Etranacogene dezaparvovec in people with hemophilia B and without adeno-associated virus serotype 5 neutralizing antibodies: a 4-year subgroup analysis of the Health Outcomes with Padua Gene; Evaluation in Hemophilia B (HOPE-B) trial · Priyanka Raheja · 2025 · 4 citations · Cited by this paper
  36. A comprehensive care pathway of gene therapy for hemophilia based on current guideline documents and summary of product characteristics: communication from the ISTH SSC working group on gene therapy · Caroline M. A. Mussert · 2025 · 3 citations · Cited by this paper
  37. Total and Neutralizing Antibody Seroprevalence of Hepatotropic Adeno-Associated Virus Among Healthy and Hemophilia A or B Population from India · Hubert Darius J. Daniel · 2025 · 2 citations · Cited by this paper
  38. Haemophilia Gene Therapy: Patient Selection and Experience in the Era of Precision Medicine · Dr Sara Boyce · 2024 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)